HHS grants FDA authority to oversee clinical trial data

09/25/2012 | Pharmalot.com

The FDA has been given the authority to investigate potentially false, misleading or missing data from studies filed to the database ClinicalTrials.gov, according to an announcement in the Federal Register. The move follows reports of cases where complete trial data was not provided.

View Full Article in:

Pharmalot.com

Published in Briefs: